-
1
-
-
17844373254
-
Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents
-
Iakovou, I., Schmidt, T., Bonizzoni, E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293 (2005), 2126–2130.
-
(2005)
JAMA
, vol.293
, pp. 2126-2130
-
-
Iakovou, I.1
Schmidt, T.2
Bonizzoni, E.3
-
2
-
-
33847705701
-
Stent thrombosis in randomized clinical trials of drug-eluting stents
-
Mauri, L., Hsieh, W.H., Massaro, J.M., Ho, K.K., D'Agostino, R., Cutlip, D.E., Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 356 (2007), 1020–1029.
-
(2007)
N Engl J Med
, vol.356
, pp. 1020-1029
-
-
Mauri, L.1
Hsieh, W.H.2
Massaro, J.M.3
Ho, K.K.4
D'Agostino, R.5
Cutlip, D.E.6
-
3
-
-
84874216783
-
Antiplatelet therapy and long-term clinical outcome after sirolimus-eluting stent implantation: 5-year outcome of the j-Cypher registry
-
Kimura, T., Morimoto, T., Nakagawa, Y., et al. Antiplatelet therapy and long-term clinical outcome after sirolimus-eluting stent implantation: 5-year outcome of the j-Cypher registry. Cardiovasc Interv Ther 27 (2012), 181–188.
-
(2012)
Cardiovasc Interv Ther
, vol.27
, pp. 181-188
-
-
Kimura, T.1
Morimoto, T.2
Nakagawa, Y.3
-
4
-
-
84860135329
-
Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial
-
Valgimigli, M., Campo, G., Monti, M., et al., Prolonging Dual Antiplatelet Treatment After Grading Stent-Induced Intimal Hyperplasia Study (PRODIGY) Investigators. Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial. Circulation 125 (2012), 2015–2026.
-
(2012)
Circulation
, vol.125
, pp. 2015-2026
-
-
Valgimigli, M.1
Campo, G.2
Monti, M.3
-
5
-
-
84926332974
-
ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting
-
Schulz-Schüpke, S., Byrne, R.A., Ten Berg, J.M., et al., Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) Trial Investigators. ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting. Eur Heart J 36 (2015), 1252–1263.
-
(2015)
Eur Heart J
, vol.36
, pp. 1252-1263
-
-
Schulz-Schüpke, S.1
Byrne, R.A.2
Ten Berg, J.M.3
-
6
-
-
84923348829
-
Six-month versus 24-month dual antiplatelet therapy after implantation of drug eluting stents in patients non-resistant to aspirin: ITALIC, a randomized multicenter trial
-
Gilard, M., Barragan, P., Noryani, A.A., et al. Six-month versus 24-month dual antiplatelet therapy after implantation of drug eluting stents in patients non-resistant to aspirin: ITALIC, a randomized multicenter trial. J Am Coll Cardiol 65 (2015), 777–786.
-
(2015)
J Am Coll Cardiol
, vol.65
, pp. 777-786
-
-
Gilard, M.1
Barragan, P.2
Noryani, A.A.3
-
7
-
-
84918810121
-
Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial
-
Colombo, A., Chieffo, A., Frasheri, A., et al. Second-generation drug-eluting stent implantation followed by 6- versus 12-month dual antiplatelet therapy: the SECURITY randomized clinical trial. J Am Coll Cardiol 64 (2014), 2086–2097.
-
(2014)
J Am Coll Cardiol
, vol.64
, pp. 2086-2097
-
-
Colombo, A.1
Chieffo, A.2
Frasheri, A.3
-
8
-
-
84856452781
-
Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study
-
Gwon, H.C., Hahn, J.Y., Park, K.W., et al. Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study. Circulation 125 (2012), 505–513.
-
(2012)
Circulation
, vol.125
, pp. 505-513
-
-
Gwon, H.C.1
Hahn, J.Y.2
Park, K.W.3
-
9
-
-
84918772240
-
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents
-
Mauri, L., Kereiakes, D.J., Yeh, R.W., et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 371 (2014), 2155–2166.
-
(2014)
N Engl J Med
, vol.371
, pp. 2155-2166
-
-
Mauri, L.1
Kereiakes, D.J.2
Yeh, R.W.3
-
10
-
-
84861371093
-
Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials
-
Stefanini, G.G., Byrne, R.A., Serruys, P.W., et al. Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials. Eur Heart J 33 (2012), 1214–1222.
-
(2012)
Eur Heart J
, vol.33
, pp. 1214-1222
-
-
Stefanini, G.G.1
Byrne, R.A.2
Serruys, P.W.3
-
11
-
-
84893663171
-
Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials
-
Sabaté, M., Räber, L., Heg, D., et al. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials. J Am Coll Cardiol Intv 7 (2014), 55–63.
-
(2014)
J Am Coll Cardiol Intv
, vol.7
, pp. 55-63
-
-
Sabaté, M.1
Räber, L.2
Heg, D.3
-
12
-
-
0018687930
-
A multiple testing procedure for clinical trials
-
O'Brien, P.C., Fleming, T.R., A multiple testing procedure for clinical trials. Biometrics 35 (1979), 549–556.
-
(1979)
Biometrics
, vol.35
, pp. 549-556
-
-
O'Brien, P.C.1
Fleming, T.R.2
-
13
-
-
0037453968
-
Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial
-
Lincoff, A.M., Bittl, J.A., Harrington, R.A., et al. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial. JAMA 289 (2003), 853–863.
-
(2003)
JAMA
, vol.289
, pp. 853-863
-
-
Lincoff, A.M.1
Bittl, J.A.2
Harrington, R.A.3
-
14
-
-
79959550517
-
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium
-
Mehran, R., Rao, S.V., Bhatt, D.L., et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123 (2011), 2736–2747.
-
(2011)
Circulation
, vol.123
, pp. 2736-2747
-
-
Mehran, R.1
Rao, S.V.2
Bhatt, D.L.3
-
15
-
-
34247558672
-
Clinical end points in coronary stent trials: a case for standardized definitions
-
Cutlip, D.E., Windecker, S., Mehran, R., et al., Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 115 (2007), 2344–2351.
-
(2007)
Circulation
, vol.115
, pp. 2344-2351
-
-
Cutlip, D.E.1
Windecker, S.2
Mehran, R.3
-
16
-
-
84945957847
-
Final 3-year outcome of a randomized trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer: NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-Eluting Stent Trial
-
Natsuaki, M., Kozuma, K., Morimoto, T., et al. Final 3-year outcome of a randomized trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer: NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-Eluting Stent Trial. Circ Cardiovasc Interv, 8, 2015, e002817.
-
(2015)
Circ Cardiovasc Interv
, vol.8
, pp. e002817
-
-
Natsuaki, M.1
Kozuma, K.2
Morimoto, T.3
-
17
-
-
84959529733
-
Six versus 12 months of dual antiplatelet therapy after implantation of biodegradable polymer sirolimus-eluting stent: randomized substudy of the I-LOVE-IT 2 trial
-
Han, Y., Xu, B., Xu, K., et al. Six versus 12 months of dual antiplatelet therapy after implantation of biodegradable polymer sirolimus-eluting stent: randomized substudy of the I-LOVE-IT 2 trial. Circ Cardiovasc Interv, 9, 2016, e003145.
-
(2016)
Circ Cardiovasc Interv
, vol.9
, pp. e003145
-
-
Han, Y.1
Xu, B.2
Xu, K.3
-
18
-
-
85011390813
-
Initial experience of bioabsorbable polymer everolimus-eluting synergy stents in high-risk patients undergoing complex percutaneous coronary intervention with early discontinuation of dual-antiplatelet therapy
-
Noad, R.L., Hanratty, C.G., Walsh, S.J., Initial experience of bioabsorbable polymer everolimus-eluting synergy stents in high-risk patients undergoing complex percutaneous coronary intervention with early discontinuation of dual-antiplatelet therapy. J Invasive Cardiol 29 (2017), 36–41.
-
(2017)
J Invasive Cardiol
, vol.29
, pp. 36-41
-
-
Noad, R.L.1
Hanratty, C.G.2
Walsh, S.J.3
-
19
-
-
84993661556
-
Efficacy and safety of dual antiplatelet therapy after Complex PCI
-
Giustino, G., Chieffo, A., Palmerini, T., et al. Efficacy and safety of dual antiplatelet therapy after Complex PCI. J Am Coll Cardiol 68 (2016), 1851–1864.
-
(2016)
J Am Coll Cardiol
, vol.68
, pp. 1851-1864
-
-
Giustino, G.1
Chieffo, A.2
Palmerini, T.3
-
20
-
-
84938234622
-
Longer- versus shorter-duration dual-antiplatelet therapy after drug-eluting stent placement: a systematic review and meta-analysis
-
Spencer, F.A., Prasad, M., Vandvik, P.O., Chetan, D., Zhou, Q., Guyatt, G., Longer- versus shorter-duration dual-antiplatelet therapy after drug-eluting stent placement: a systematic review and meta-analysis. Ann Intern Med 163 (2015), 118–126.
-
(2015)
Ann Intern Med
, vol.163
, pp. 118-126
-
-
Spencer, F.A.1
Prasad, M.2
Vandvik, P.O.3
Chetan, D.4
Zhou, Q.5
Guyatt, G.6
-
21
-
-
77953668423
-
Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years
-
Ko, D.T., Yun, L., Wijeysundera, H.C., et al. Incidence, predictors, and prognostic implications of hospitalization for late bleeding after percutaneous coronary intervention for patients older than 65 years. Circ Cardiovasc Interv 3 (2010), 140–147.
-
(2010)
Circ Cardiovasc Interv
, vol.3
, pp. 140-147
-
-
Ko, D.T.1
Yun, L.2
Wijeysundera, H.C.3
-
22
-
-
84942826111
-
Balancing long-term risks of ischemic and bleeding complications after percutaneous coronary intervention with drug-eluting stents
-
Matteau, A., Yeh, R.W., Camenzind, E., et al. Balancing long-term risks of ischemic and bleeding complications after percutaneous coronary intervention with drug-eluting stents. Am J Cardiol 116 (2015), 686–693.
-
(2015)
Am J Cardiol
, vol.116
, pp. 686-693
-
-
Matteau, A.1
Yeh, R.W.2
Camenzind, E.3
-
23
-
-
84940050465
-
Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention
-
Généreux, P., Giustino, G., Witzenbichler, B., et al. Incidence, predictors, and impact of post-discharge bleeding after percutaneous coronary intervention. J Am Coll Cardiol 66 (2015), 1036–1045.
-
(2015)
J Am Coll Cardiol
, vol.66
, pp. 1036-1045
-
-
Généreux, P.1
Giustino, G.2
Witzenbichler, B.3
-
24
-
-
0037182764
-
Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use
-
Lai, K.C., Lam, S.K., Chu, K.M., et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 346 (2002), 2033–2038.
-
(2002)
N Engl J Med
, vol.346
, pp. 2033-2038
-
-
Lai, K.C.1
Lam, S.K.2
Chu, K.M.3
-
25
-
-
78149487926
-
Clopidogrel with or without omeprazole in coronary artery disease
-
Bhatt, D.L., Cryer, B.L., Contant, C.F., et al. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 363 (2010), 1909–1917.
-
(2010)
N Engl J Med
, vol.363
, pp. 1909-1917
-
-
Bhatt, D.L.1
Cryer, B.L.2
Contant, C.F.3
|